NCT07000604 Effect of ınhaler Use on Oral Health in COPD Patients
| NCT ID | NCT07000604 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Çankırı Karatekin University |
| Condition | Chronic Obstructive Pulmonary Disease (COPD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-05-30 |
| Primary Completion | 2025-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-05-30 with a primary completion date of 2025-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study was to evaluate the effect of oral health education given to individuals diagnosed with COPD and using inhaled medication.
Eligibility Criteria
Inclusion Criteria: * Diagnosed with COPD for at least 6 months, * Outpatient and inpatient, * Consent to participate in the research, * Not under the age of eighteen, * With a metered dose inhaler (MDI) in treatment, * No communication barriers, * No COPD exacerbation and/or respiratory tract infection, * According to the GOLD report; mild (Stage 1), moderate (Stage 2), severe (Stage 3). Exclusion Criteria: * Diagnosed with COPD for less than 6 months, * Refused to participate in the research, * Treatment without metered dose inhalers (MDIs), * Uncommunicative, * Those who withdrew from participating in the study during data collection, * Not completing the survey, * COPD exacerbation and/or respiratory tract infection,
Contact & Investigator
Betül Yalçın, 2
PRINCIPAL INVESTIGATOR
Çankırı Karatekin University
Frequently Asked Questions
Who can join the NCT07000604 clinical trial?
This trial is open to participants of all sexes, aged 35 Years or older, up to 80 Years, studying Chronic Obstructive Pulmonary Disease (COPD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07000604 currently recruiting?
Yes, NCT07000604 is actively recruiting participants. Contact the research team at betulozylmz@gmail.com for enrollment information.
Where is the NCT07000604 trial being conducted?
This trial is being conducted at Çankırı, Turkey (Türkiye).
Who is sponsoring the NCT07000604 clinical trial?
NCT07000604 is sponsored by Çankırı Karatekin University. The principal investigator is Betül Yalçın, 2 at Çankırı Karatekin University. The trial plans to enroll 80 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.